| Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More | Frank Vinluan | 02/14/20 | National |
| Review: Inside the House of Lies at Theranos | Wade Roush | 06/24/19 | National |
| Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More | Frank Vinluan | 04/26/19 | National |
| Tech Leaders Weigh In on Tim Berners-Lee’s “Contract for the Web” | Bernadette Tansey | 01/07/19 | National |
| Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away | Ben Fidler | 09/07/18 | National |
| Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More | Frank Vinluan | 06/22/18 | National |
| Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid | Robert Buderi | 05/15/18 | National |
| Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts | Ben Fidler | 04/13/18 | National |
| Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks | Ben Fidler | 03/23/18 | National |
| Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More | Frank Vinluan | 03/16/18 | National |
| Charged With Fraud, Theranos CEO Elizabeth Holmes Cuts Deal with Feds | Alex Lash | 03/14/18 | San Francisco |
| Xconomy Bookclub: Village Capital CEO Tackles Innovation’s “Blind Spot” | Angela Shah | 10/17/17 | Texas |
| Dramatic Capital Inflows Continue in 2Q17… Trouble Ahead? | Michael A. Greeley | 08/03/17 | Boston |
| Trump Policies, Paperwork, & More: Advice for Startup Founders | Jeff Buchanan | 02/24/17 | Wisconsin |
| Seventh Sense Gets Initial FDA Clearance for Simple Blood-Draw Device | Jeff Bauter Engel | 02/23/17 | Boston |
| What Is Causing Startups to Go Bankrupt? | Shellye Archambeau | 12/20/16 | San Francisco |
| Seventh Sense Biosystems Sucks In $10M for Simple Blood-Draw Device | Jeff Bauter Engel | 11/18/16 | Boston |
| Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More | Alex Lash | 11/18/16 | National |
| Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More | Alex Lash | 10/07/16 | National |
| Austin’s EverlyWell Helps Consumers Do More Health Tests at Home | Angela Shah | 09/16/16 | Texas |
| Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More | Ben Fidler | 08/05/16 | National |
| Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News | Alex Lash | 07/15/16 | National |
| Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More | Ben Fidler | 06/10/16 | National |
| Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More | Ben Fidler | 05/27/16 | National |
| West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More | Alex Lash | 04/22/16 | San Francisco |
| Biotech’s Recent Headlines, Reimagined In Verse and On Stage | Alex Lash | 02/16/16 | National |
| Medical Test Validity Will Be Debated In 2016: 5 Storylines To Watch | Laura Strong | 01/14/16 | Wisconsin |
| Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News | Bruce V. Bigelow | 11/13/15 | San Diego |
| West Coast Biotech Roundup: Arena, Frazier, Kura, and Theranos | Bruce V. Bigelow | 10/30/15 | San Diego |
| What’s Your DNA Worth? The Scramble To Cash In On the Genome | Alex Lash | 10/20/15 | National |
